Ibandronate Sodium
10 NDCs across 7 manufacturers|10 Generic,0 Brand
Ibandronate Sodium is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 16, 2003, and the first generic was approved Mar 19, 2012. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $25 million on Ibandronate Sodium across 859,000 claims for 261,000 beneficiaries.
Ibandronate Sodium is available as 10 NDCs from 7 manufacturers (10 generic, 0 brand), with NADAC prices from $2.68 to $3.23 per EA — a 21% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
7
competing in market
Price Spread
$2.68 – $3.23
per EA, 7 of 10 NDCs
7d Activity
avg -2.8% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Apotex Corp. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Bisphosphonate class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing IBANDRONATE SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
IBANDRONATE 3 MG/3 ML SYRINGE | $54.2117 per ML | — |
IBANDRONATE 3 MG/3 ML SYRINGE | $52.6478 per ML | — |
IBANDRONATE 3 MG/3 ML SYRINGE | $52.6478 per ML | — |
IBANDRONATE SODIUM 150 MG TAB | $3.2323 per EA | — |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
IBANDRONATE SODIUM 150 MG TAB | $2.6751 per EA | -2.81% |
Frequently Asked Questions
What is Ibandronate Sodium used to treat?
Ibandronate Sodium is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
When did Ibandronate Sodium become available as a generic?
FDA approved the first generic Ibandronate Sodium (ANDA) on Mar 19, 2012. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ibandronate Sodium?
In 2024, Medicare Part D spent $25 million on Ibandronate Sodium across 859,000 claims for 261,000 beneficiaries.
How many Ibandronate Sodium products are on the market?
The Ibandronate Sodium drug market contains 10 NDCs from 7 manufacturers — 10 generic and 0 brand products.
What is the price range for Ibandronate Sodium?
NADAC reference prices for Ibandronate Sodium range from $2.6751 to $3.2323 per EA — a 21% difference between cheapest and most expensive. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Ibandronate Sodium?
7 manufacturers list Ibandronate Sodium in NADAC. Ranked by number of NDCs, the largest are Apotex Corp. (2), Dr. Reddy's Laboratories Inc. (2), Macleods Pharmaceuticals Limited (2), Mylan Institutional LLC (1), Eugia US LLC (1).
How has the price of Ibandronate Sodium changed recently?
Over the past 7 days, 0 Ibandronate Sodium NDCs rose and 6 fell, with a market-wide average change of -2.8%.